y-Glutamyltranspeptidase, alkaline phosphatase and leucine aminopeptidase activities in the sera of patients affected by various liver diseases were identified after gel filtration on Sephadex G 200. Protein was scanned at 280 nm and the 19 S, 7 S and 4 S peaks obtained were used as points of reference. Only one peak of y-glutamyltranspeptidase activity, at the level of the 19 S protein fraction, was found in the sera of all patients-studied. Alkaline phosphatase and leucine aminopeptidase activity was divided into two peaks corresponding to the 19 and 7 S protein fractions. In cholestasis cases, whatever the pathology, alkaline phosphatase and leucine aminopeptidase activity present in the 19 S fraction were always more than 20% of the total activity, often reaching values above 40% of the total.
Although many workers, using different methods, have proved the presence of y-glutamyltranspeptidase (EC 2.3.2.1), alkaline phosphatase (EC 3.1.3.1) and leucine aminopeptidase (EC 3.4.1.1) isoenzymes in the serum in various disease states, the results are not in agreement and generally are not of sufficient clarity for application to clinical work. This paper reports data concerning the estimation of these isoenzymes by means of gel filtration on Sephadex G 200 in the serum of patients with various liver diseases. Previous Chromatographie estimations of y-glutamyltranspeptidase by means of gel filtration have been entirely contradictory. ORLOWSKI and SZCZEKLIK (1) found three peaks of enzyme activity: each peak was eluted with one of the three proteic fractions: the highest y-glutamyltranspeptidase activity was eluted with albumin. Κοκοτ and KUSKA (2), JACYSZYN and LAURSEN (3) also found three peaks: they reported that the highest one was eluted with the 19 S fraction. As far as the other two peaks are concerned, Κοκοτ and KUSKA found them in the second protein fraction, while the Other workers found them before the first fraction. Only a few data are available about the gel filtration of alkaline phosphatase activity on Sephadex G 200. In normal serum a fraction of alkaline phosphatase activity at the level of the second peak eluted from the gel has been reported (4): in about 30% of the cases a zone of activity (about 5% of the total activity) has been noted at the level of first peak.
In disease, two fractions are always observed: DUNNE and coworkers (5) showed that the first fraction is about 2% of the total activity in non-neoplastic bony diseases, 10% in neoplastic bony diseases, 12% in nonneoplastic liver diseases and 32% in metastatic liver tumours. According to these authors, therefore, the high concentration of alkaline phosphatase activity present in the first fraction is characteristic of metastatic tumours. Recently JENNINGS and coworkers (6) seem to have confirmed these results.
Material and methods

Sephadex gel filtration
We performed gel filtration on Sephadex G 200 (PharmaciaUpsala, Sweden). Column size was 45 χ 2.5 according to FLODIN and KILLANDER'S method (7). Two ml of serum were applied to the column for each Chromatographie estimation. Tris buffer O.!M pH 8.1 + NaCl 0.5M was used for the elution. Protein concentration was measured at 280 nm by a Uvicord Automatic Ultraviolet Absorption Detector. The eluate was collected automatically in 3 ml fractions.
Determination of γ-glntamjltranspeptidase
We determined the y-glutamyltranspeptidase activity by the method of SZASZ (8), using L-y-glutamyl-/>-nitroanilide as substrate.
Determination of alkalim pbospbatase
Alkaline phosphatase activity was determined by the kinetic test at 25° and a wave length of 405 nm, the substrate being />-nitrophenylphosphate (9).
Icteo and Ronchi: Gel Filtration of Serum Enzymes in Liver Diseases
As we used a pH 8.1 buffer for gel filtration, it was necessary to correct the pH of the mixture in the cuvette to pH 10.5 with NaOH, because this pH is required for the maximum activity of alkaline phosphatase.
Determination of lencine aminopeptidase
Leucine aminopeptidase activity, was also determined by the kinetic test at 25° and a wave length of 405 nm. This method utilizes as substrate L-leucyl-/>-nitroanilide (10). The case material included 8 patients with acute hepatitis, 7 with chronic hepatitis, 8 with portal cirrhosis, 21 with cholestäsis (1 with cancer of the head of the pancreas, 1 with cancer of choledochus, 4 with choledocholithiasis, 7 with primary or metastatic liver neoplasms, 1 with cholestäsis in HODGKIN disease, 3. with cholangitis, 3 with primary or secondary biliary cirrhosis and 1 with drug cholestäsis). The diagnosis was based upon clinical, biochemical and, in most cases, histological or peritoneoscopic criteria. In some of these cases, after gel filtration of serum, only one or two enzymes were estimated. In our laboratories normal values for y-glutamyltranspeptidase are 8-28 U/l of serum, for alkaline phosphatase 12-30 U/l of serum and for leucine aminopeptidase 8-22 U/l of serum.
Results
Rgure 1 shows as a standard the protein profile of normal serum, submitted to gel filtration on a Se-·-· 6 -6-Effluent volume Fig. 1 Gel filtration patterns of sera from normal subjects. Shaded areas: activity of y-glutamyltranspeptidase, alkaline phosphatase and leucine aminopeptidase phadex G 200 column. The proteins are eluted in three main peaks corresponding to the 19 S, 7 S and 4 S (and albumin) fractions, as defined by ultracentrif ugation (7). y-Glutamyl transpeptidase activity appears only in the first eluted protein fraction. Alkaline phosphatase and leucine aminopeptidase are present either in the first or in the second eluted protein fraction: but the activity is mainly located in the second fraction, because the first fraction levels never exceed 10% Of the total activity. Tables 1, 2 and 3 show the distribution of y-glutamyltranspeptidase, alkaline phosphatase and leucine aminopeptidase in the three eluted protein fractions in the morbid forms we .considered. It is evident thatglutamyltranspeptidase is always present only in the first fraction eluted from the gel, and it shows no difference between any of the liver diseases. Alkaline phosphatase activity, on the other hand, shows variations: in acute hepatitis, chronic hepatitis and cirrhosis, the activity which appears in the first eluted fraction is quite small -often indeterminate -and Leucine aminopeptidase activity appears to behave in a similar fashion. The percentage of leucine aminopepitdase activity present in the first protein peak eluted by gel is quite high in cholestasis. A notable increase of the first fraction was seen even in the cirrhosis cases (values of about 25-30%). Figures 2 and 3 show as a standard the protein profiles and related zones of activity of y-glutamyltranspeptidase, alkaline phosphatase and leucine aminopeptidase in patients affected respectively by acute hepatitis and cholestasis.
Discussion
Only one peak of y-glutamyltranspeptidase activity was found in the sera of all cases studied by gel filtration on Sephadex G 200. This peak was eluted together with the first protein fraction. Therefore y-glutamyltranspeptidase seems to be a rather homogeneous enzyme with molecular weight about 200,000. However some little differences in molecular weight can be shown "when the eluted fractions with y-glutamyltranspeptidase activities are again characterized by means of gel filtration (11). The different results of other authors might be explained by the formation of multiple molecular forms as speculated by ORLOWSKI and SZCZEKLIK (1) or by the different methods in enzyme assay. It might also be that colorimetric methods used to test y-glutamyltranspeptidase levels detect non-specific enzyme activities. Otherwise it is difficult to see how LAURSEN and coworkers (3) found y-glutamyltranspeptidase activity peaks which were eluted even earlier than the heaviest protein fraction.
The detection on Sephadex G 200 of the serial alkaline phosphatase activity showed a characteristic pattern in the sera of patients suffering from cholestasis. In fact only in these patients was it possible to find a high level of alkaline phosphatase activity present in the first eluted fraction. DUNNE and coworkers (5) and JENNINGS and coworkers (6) asserted that this pattern was specific for the serum of patients with primary or metastatic liver tumours: but DUNNE and coworkers have not studied the sera of patients suffering from other forms of cholestasis; and of only two patients affected by benign obstruction considered by JENNINGS and coworkers, one showed high alkaline phosphatase activity (31% of total) in the first fraction. We therefore believe that the presence of a high level at the first peak is found in all cases of cholestasis, whatever the cause. NEWTON and coworkers (12) and DUNNE and cor workers (5) suggest that this alkaline phosphatase activity related to 19 S fraction could be a lipoprotein complex. The results of JENNINGS and coworkers (6) seem to support this view. These authors observed that, after n-butanol extraction of concentrated 19 S column eluents, alkaline phosphatase activity moved to the 7 S position. On the other hand, an increase in lipoproteins has also been observed in obstructive jaundice (13, 14) . However, since in some cases JENNINGS and coworkers observed a considerable loss of alkaline phosphatase activity after n^butanol extraction, we cannot exclude the possibility that alkaline phosphatase activity related to the 19 S fraction may partly be an enzyme polymer (5).
As far as the leucine aminopeptidase activity is concerned, we have observed the presence of two peaks after serum gel filtration, eluting at the level of 19 S and 7 S protein fractions respectively. The changes of the percentages of these two peaks in different liver diseases are similar to the changes in alkaline phosphatase: so the deductions made-about alkaline phosphatase activity apply equally to leucine aminopeptidase.
